Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria

Phase II Randomized Study of Tin Mesoporphyrin for Neonatal Hyperbilirubinemia

NCT00004381 ·Status: COMPLETED ·Phase: PHASE2

Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

NCT02180412 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis

NCT00000595 ·Status: COMPLETED ·Phase: PHASE2

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

NCT00395993 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of Arginine as a Treatment for Sickle Cell Anemia

NCT00513617 ·Status: COMPLETED ·Phase: PHASE2

Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia

NCT00661726 ·Status: COMPLETED ·Phase: PHASE2

Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease

NCT00459225 ·Status: WITHDRAWN ·Phase: NA

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

NCT06546670 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Total Dose Infusion of Ferumoxytol(1020mg) in 15 Minutes for Iron Deficiency Anemia

NCT01374919 ·Status: COMPLETED ·Phase: NA

Longitudinal Study of the Porphyrias

NCT01561157 ·Status: RECRUITING

Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria

NCT00004940 ·Status: COMPLETED ·Phase: PHASE3

Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias

NCT00061763 ·Status: COMPLETED ·Phase: PHASE2

Combination Deferasirox and Deferiprone for Severe Iron Overload in Thalassemia

NCT01709032 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)

NCT03401112 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease

NCT01000155 ·Status: TERMINATED ·Phase: PHASE2

A Stratified Sickle Event Randomized Trial (ASSERT)

NCT00102791 ·Status: TERMINATED ·Phase: PHASE3

Assessment of Algorithm-Based Hydroxyurea Dosing on Fetal Hemoglobin Response, Acute Complications, and Organ Function in People With Sickle Cell Disease

NCT02225132 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)

NCT03285178 ·Status: COMPLETED ·Phase: PHASE2

A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer

NCT02905539 ·Status: COMPLETED ·Phase: PHASE4

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera

NCT05210790 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment

NCT04058197 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron Overload

NCT00560820 ·Status: COMPLETED ·Phase: PHASE1

Deferoxamine for the Treatment of Hemochromatosis

NCT00001203 ·Status: COMPLETED

Oral Iron for Erythropoietic Protoporphyrias

NCT02979249 ·Status: COMPLETED ·Phase: NA

Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function

NCT06145282 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2